4AB:FRA
AbbVie
231,00 €
arrow_downward
-1,87%(-4,40) 1K
30-sen, 8:00:42 (GMT+2) · EUR
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto4AB tikeri uchun statistika yaratilmoqda...
Ochish
231,00 €
Yuqori
231,00 €
Past
231,00 €
Bozor kapitali
465,26 mlrd
Oʻrtacha hajm
52,00
Hajmi
0,00
52 haftalik eng yuqori
235,70 €
52 haftalik eng past
167,55 €
Xodimlar soni
57 ming
Ochish
231,00 €
Yuqori
231,00 €
Past
231,00 €
Bozor kapitali
465,26 mlrd
Oʻrtacha hajm
52,00
Hajmi
0,00
52 haftalik eng yuqori
235,70 €
52 haftalik eng past
167,55 €
Xodimlar soni
57 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investing.com Canada
·
20 daqiqa oldin
AbbVie presents phase 1 data for obesity drug ABBV-295 By Investing.com
Investing News Network
·
2 soat oldin
AbbVie Highlights Positive Results from the Phase 2 APEX Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at EADV 2026
Stock Titan
·
5 soat oldin
Three late-breaking reports will be part of AbbVie's 60 research presentations on skin diseases.
Benzinga
·
11 soat oldin
If You Invested $1000 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
Profil
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
AbbVie haqida
CEORobert A. Michael
Xodimlar soni57 ming
Asos solingan10-apr, 2012
Bosh ofislarNorth Chicago, Illinoys, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytabbvie.com